carers. • their diagnosis, possible triggers
1 Nov 2017 Abstract: Biological therapy became available for psoriasis with the introduction of alefacept at the beginning of this century. Up to then, systemic treatment options comprised small molecule drugs, targeting the immune system in a non-specific manner. The first biologics targeted T-cell activation.
17 Feb 2009 FROM THE ACADEMY. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. Alan Menter, MD, Chair,a Neil J. Korman, MD, PhD,b Craig A. Elmets, MD,c Steven R. Feldman, MD, PhD,d.
FROM THE ACADEMY. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. Work Group: Alan Menter, MD, Chair,a Alice Gottlieb, MD, PhD,b Steven R. Feldman, MD, PhD,c. Abby S. Van Voorhees, MD,d
1 May 2017 2. Version Control. 3. Introduction. 3. Purpose and Summary. 3. Criteria for Referral to Specialist Dermatology Services. 4. Adult Psoriasis Topical Treatment Pathway. 5. Children and Young People Psoriasis Topical Treatment Pathway. 5. Suitable Quantities of Preparations to be Prescribed. 6. Bibliography.
Identify and describe the morphology of psoriasis. • Describe associated triggers or risk factors for psoriasis. • Describe the clinical features of psoriatic arthritis. • List the basic principles of treatment for psoriasis. • Discuss the emotional and psychosocial impact of psoriasis on patients. • Determine when to refer a patient with
9 Feb 2011 Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusions. Work Group: Chair, Alan Menter, MD,a Neil J. Korman, MD, PhD,b Craig A. Elmets, MD,c.

Annons

The photo has no tags

March 2018